GSK, Roche osteoporosis deal

Roche (SWX:ROCZ) and GlaxoSmithKline (GSK; LSE:GSK) will jointly develop and promote ROCZ's ibandronate, which is in Phase III testing to treat and prevent post-menopausal osteoporosis. The companies ...